Compile Data Set for Download or QSAR
maximum 50k data
Found 357 with Last Name = 'den hartog' and Initial = 'ja'
TargetIntegrin alpha-IIb/beta-3(Homo sapiens (Human))
Solvay Pharma

Curated by ChEMBL
LigandPNGBDBM50003852((4-{2-[(4-Carbamimidoyl-benzoyl)-methyl-amino]-ace...)
Affinity DataIC50:  1nMAssay Description:Inhibition of fibrinogen binding to platelet glycoprotein alpha IIb beta-3 integrin in ELISAMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetIntegrin alpha-IIb/beta-3(Homo sapiens (Human))
Solvay Pharma

Curated by ChEMBL
LigandPNGBDBM50092125(CHEMBL37300 | {4-[4-(4-Carbamimidoyl-phenyl)-piper...)
Affinity DataIC50:  2nMAssay Description:Inhibition of fibrinogen binding to platelet glycoprotein alpha IIb beta-3 integrin in ELISAMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetIntegrin alpha-IIb/beta-3(Homo sapiens (Human))
Solvay Pharma

Curated by ChEMBL
LigandPNGBDBM50037970(CHEMBL36326 | GR-144053 | GR-144053F | {4-[4-(4-Ca...)
Affinity DataIC50:  7.90nMAssay Description:Inhibition of fibrinogen binding to platelet glycoprotein alpha IIb beta-3 integrin in ELISAMore data for this Ligand-Target Pair
TargetIntegrin alpha-IIb/beta-3(Homo sapiens (Human))
Solvay Pharma

Curated by ChEMBL
LigandPNGBDBM50215567(CHEMBL37299)
Affinity DataIC50:  25nMAssay Description:Inhibition of fibrinogen binding to platelet glycoprotein alpha IIb beta-3 integrin in ELISAMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetMembrane primary amine oxidase(Homo sapiens (Human))
Acucela

US Patent
LigandPNGBDBM619639((E)-4-(6-((2-(aminomethyl)-3-fluoroallyl)oxy)benzo...)
Affinity DataIC50: <100nMAssay Description:The capability of compounds described herein to inhibit the enzymatic activity of vascular adhesion protein-1 (VAP-1) was determined by fluorometric ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetMembrane primary amine oxidase(Homo sapiens (Human))
Acucela

US Patent
LigandPNGBDBM619640((E)-6-((2-(aminomethyl)-3- fluoroallyl)oxy)-N-((2,...)
Affinity DataIC50: <100nMAssay Description:The capability of compounds described herein to inhibit the enzymatic activity of vascular adhesion protein-1 (VAP-1) was determined by fluorometric ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetAmine oxidase [flavin-containing] A(Homo sapiens (Human))
Acucela

US Patent
LigandPNGBDBM619641((E)-6-((2-(Aminomethyl)-3-fluoroallyl)oxy)-N-((2,6...)
Affinity DataIC50: <100nMAssay Description:The capability of compounds described herein to inhibit MAO was determined using a modified Promega MAO-Glo assay kit. The substrate ((4S)-4,5-dihydr...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetAmine oxidase [flavin-containing] B(Homo sapiens (Human))
Acucela

US Patent
LigandPNGBDBM619641((E)-6-((2-(Aminomethyl)-3-fluoroallyl)oxy)-N-((2,6...)
Affinity DataIC50: <100nMAssay Description:The capability of compounds described herein to inhibit MAO was determined using a modified Promega MAO-Glo assay kit. The substrate ((4S)-4,5-dihydr...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetMembrane primary amine oxidase(Homo sapiens (Human))
Acucela

US Patent
LigandPNGBDBM619642((Z)-5-((6-((2-(aminomethyl)-3-fluoroallyl)oxy)benz...)
Affinity DataIC50: <100nMAssay Description:The capability of compounds described herein to inhibit the enzymatic activity of vascular adhesion protein-1 (VAP-1) was determined by fluorometric ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetMembrane primary amine oxidase(Homo sapiens (Human))
Acucela

US Patent
LigandPNGBDBM619643((Z)-6-((2-(aminomethyl)-3-fluoroallyl)oxy)-N-(pyri...)
Affinity DataIC50: <100nMAssay Description:The capability of compounds described herein to inhibit the enzymatic activity of vascular adhesion protein-1 (VAP-1) was determined by fluorometric ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetMembrane primary amine oxidase(Homo sapiens (Human))
Acucela

US Patent
LigandPNGBDBM619586((E)-2-(((2-cyclopentylbenzo[d]oxazol-6-yl)oxy)meth...)
Affinity DataIC50: <100nMAssay Description:The capability of compounds described herein to inhibit the enzymatic activity of vascular adhesion protein-1 (VAP-1) was determined by fluorometric ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetMembrane primary amine oxidase(Homo sapiens (Human))
Acucela

US Patent
LigandPNGBDBM619587(4-((2-butylbenzo[d]oxazol-6-yl)oxy)-2-(fluoromethy...)
Affinity DataIC50: <100nMAssay Description:The capability of compounds described herein to inhibit the enzymatic activity of vascular adhesion protein-1 (VAP-1) was determined by fluorometric ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetAmine oxidase [flavin-containing] B(Homo sapiens (Human))
Acucela

US Patent
LigandPNGBDBM619587(4-((2-butylbenzo[d]oxazol-6-yl)oxy)-2-(fluoromethy...)
Affinity DataIC50: <100nMAssay Description:The capability of compounds described herein to inhibit MAO was determined using a modified Promega MAO-Glo assay kit. The substrate ((4S)-4,5-dihydr...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetMembrane primary amine oxidase(Homo sapiens (Human))
Acucela

US Patent
LigandPNGBDBM619588((E)-6-((2-(aminomethyl)-3-fluoroallyl)oxy)-N-(tert...)
Affinity DataIC50: <100nMAssay Description:The capability of compounds described herein to inhibit the enzymatic activity of vascular adhesion protein-1 (VAP-1) was determined by fluorometric ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetMembrane primary amine oxidase(Homo sapiens (Human))
Acucela

US Patent
LigandPNGBDBM619590((E)-3-fluoro-2-(((2-(4-phenylcyclohexyl)benzo[d]ox...)
Affinity DataIC50: <100nMAssay Description:The capability of compounds described herein to inhibit the enzymatic activity of vascular adhesion protein-1 (VAP-1) was determined by fluorometric ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetMembrane primary amine oxidase(Homo sapiens (Human))
Acucela

US Patent
LigandPNGBDBM619591(((Z)-3-fluoro-2-(((2-(3-methylpyrrolidin-1-yl)benz...)
Affinity DataIC50: <100nMAssay Description:The capability of compounds described herein to inhibit the enzymatic activity of vascular adhesion protein-1 (VAP-1) was determined by fluorometric ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetMembrane primary amine oxidase(Homo sapiens (Human))
Acucela

US Patent
LigandPNGBDBM619592((E)-3-fluoro-2-(((2-(pentan-2-yl)benzo[d]oxazol-6-...)
Affinity DataIC50: <100nMAssay Description:The capability of compounds described herein to inhibit the enzymatic activity of vascular adhesion protein-1 (VAP-1) was determined by fluorometric ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetMembrane primary amine oxidase(Homo sapiens (Human))
Acucela

US Patent
LigandPNGBDBM619593((E)-3-fluoro-2-(((2-(pentan-2-yl)benzo[d]oxazol-6-...)
Affinity DataIC50: <100nMAssay Description:The capability of compounds described herein to inhibit the enzymatic activity of vascular adhesion protein-1 (VAP-1) was determined by fluorometric ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetMembrane primary amine oxidase(Homo sapiens (Human))
Acucela

US Patent
LigandPNGBDBM619594((E)-3-fluoro-2-(((2-(pentan-2-yl)benzo[d]oxazol-6-...)
Affinity DataIC50: <100nMAssay Description:The capability of compounds described herein to inhibit the enzymatic activity of vascular adhesion protein-1 (VAP-1) was determined by fluorometric ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetMembrane primary amine oxidase(Homo sapiens (Human))
Acucela

US Patent
LigandPNGBDBM619595((E)-6-((2-(aminomethyl)-3-fluoroallyl)oxy)-N-methy...)
Affinity DataIC50: <100nMAssay Description:The capability of compounds described herein to inhibit the enzymatic activity of vascular adhesion protein-1 (VAP-1) was determined by fluorometric ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetMembrane primary amine oxidase(Homo sapiens (Human))
Acucela

US Patent
LigandPNGBDBM619596((E)-2-((6-((2-(aminomethyl)-3-fluoroallyl)oxy)benz...)
Affinity DataIC50: <100nMAssay Description:The capability of compounds described herein to inhibit the enzymatic activity of vascular adhesion protein-1 (VAP-1) was determined by fluorometric ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetMembrane primary amine oxidase(Homo sapiens (Human))
Acucela

US Patent
LigandPNGBDBM619597((E)-6-((2-(aminomethyl)-3-fluoroallyl)oxy)-N-(2-ph...)
Affinity DataIC50: <100nMAssay Description:The capability of compounds described herein to inhibit the enzymatic activity of vascular adhesion protein-1 (VAP-1) was determined by fluorometric ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetMembrane primary amine oxidase(Homo sapiens (Human))
Acucela

US Patent
LigandPNGBDBM619598((E)-6-((2-(aminomethyl)-3-fluoroallyl)oxy)-N-(2-ph...)
Affinity DataIC50: <100nMAssay Description:The capability of compounds described herein to inhibit the enzymatic activity of vascular adhesion protein-1 (VAP-1) was determined by fluorometric ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetMembrane primary amine oxidase(Homo sapiens (Human))
Acucela

US Patent
LigandPNGBDBM619599((E)-2-(((2-(tert-butyl)benzo[d]oxazol-6-yl)oxy)met...)
Affinity DataIC50: <100nMAssay Description:The capability of compounds described herein to inhibit the enzymatic activity of vascular adhesion protein-1 (VAP-1) was determined by fluorometric ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetMembrane primary amine oxidase(Homo sapiens (Human))
Acucela

US Patent
LigandPNGBDBM619600((E)-2-(((2-(4,4-dimethylpentyl)benzo[d]oxazol-6-yl...)
Affinity DataIC50: <100nMAssay Description:The capability of compounds described herein to inhibit the enzymatic activity of vascular adhesion protein-1 (VAP-1) was determined by fluorometric ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetMembrane primary amine oxidase(Homo sapiens (Human))
Acucela

US Patent
LigandPNGBDBM619601(4-(2-butylbenzo[d]oxazol-6-yl)-2-(fluoromethylene)...)
Affinity DataIC50: <100nMAssay Description:The capability of compounds described herein to inhibit the enzymatic activity of vascular adhesion protein-1 (VAP-1) was determined by fluorometric ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetMembrane primary amine oxidase(Homo sapiens (Human))
Acucela

US Patent
LigandPNGBDBM619602((E)-2-((6-((2-(aminomethyl)-3-fluoroallyl)oxy)benz...)
Affinity DataIC50: <100nMAssay Description:The capability of compounds described herein to inhibit the enzymatic activity of vascular adhesion protein-1 (VAP-1) was determined by fluorometric ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetMembrane primary amine oxidase(Homo sapiens (Human))
Acucela

US Patent
LigandPNGBDBM619603((E)-2-(((2-((3r,5r,7r)-adamantan-1-yl)benzo[d]oxaz...)
Affinity DataIC50: <100nMAssay Description:The capability of compounds described herein to inhibit the enzymatic activity of vascular adhesion protein-1 (VAP-1) was determined by fluorometric ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetMembrane primary amine oxidase(Homo sapiens (Human))
Acucela

US Patent
LigandPNGBDBM619604((E)-6-((2-(aminomethyl)-3-fluoroallyl)oxy)-N-((6-m...)
Affinity DataIC50: <100nMAssay Description:The capability of compounds described herein to inhibit the enzymatic activity of vascular adhesion protein-1 (VAP-1) was determined by fluorometric ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetMembrane primary amine oxidase(Homo sapiens (Human))
Acucela

US Patent
LigandPNGBDBM619605((Z)-2-((6-((2-(aminomethyl)-3-fluoroallyl)oxy)benz...)
Affinity DataIC50: <100nMAssay Description:The capability of compounds described herein to inhibit the enzymatic activity of vascular adhesion protein-1 (VAP-1) was determined by fluorometric ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetMembrane primary amine oxidase(Homo sapiens (Human))
Acucela

US Patent
LigandPNGBDBM619609((E)-6-((2-(aminomethyl)-3-fluoroall yl)oxy)-N-neop...)
Affinity DataIC50: <100nMAssay Description:The capability of compounds described herein to inhibit the enzymatic activity of vascular adhesion protein-1 (VAP-1) was determined by fluorometric ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetMembrane primary amine oxidase(Homo sapiens (Human))
Acucela

US Patent
LigandPNGBDBM619610((E)-6-((2-(aminomethyl)-3-fluoroallyl)oxy)-N-neope...)
Affinity DataIC50: <100nMAssay Description:The capability of compounds described herein to inhibit the enzymatic activity of vascular adhesion protein-1 (VAP-1) was determined by fluorometric ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetMembrane primary amine oxidase(Homo sapiens (Human))
Acucela

US Patent
LigandPNGBDBM619611((E)-6-((2-(aminomethyl)-3-fluoroallyl)oxy)-N-neope...)
Affinity DataIC50: <100nMAssay Description:The capability of compounds described herein to inhibit the enzymatic activity of vascular adhesion protein-1 (VAP-1) was determined by fluorometric ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetMembrane primary amine oxidase(Homo sapiens (Human))
Acucela

US Patent
LigandPNGBDBM619612((Z)-2-((6-((2-(aminomethyl)-3-fluoroallyl)oxy)benz...)
Affinity DataIC50: <100nMAssay Description:The capability of compounds described herein to inhibit the enzymatic activity of vascular adhesion protein-1 (VAP-1) was determined by fluorometric ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetMembrane primary amine oxidase(Homo sapiens (Human))
Acucela

US Patent
LigandPNGBDBM619613((Z)-2-((6-((2-(aminomethyl)-3-fluoroallyl)oxy)benz...)
Affinity DataIC50: <100nMAssay Description:The capability of compounds described herein to inhibit the enzymatic activity of vascular adhesion protein-1 (VAP-1) was determined by fluorometric ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetMembrane primary amine oxidase(Homo sapiens (Human))
Acucela

US Patent
LigandPNGBDBM619614((Z)-2-((6-((2-(aminomethyl)-3-fluoroallyl)oxy)benz...)
Affinity DataIC50: <100nMAssay Description:The capability of compounds described herein to inhibit the enzymatic activity of vascular adhesion protein-1 (VAP-1) was determined by fluorometric ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetMembrane primary amine oxidase(Homo sapiens (Human))
Acucela

US Patent
LigandPNGBDBM619615((Z)-2-(((2-butyl-2H-benzo[d][1,2,3]triazol-5-yl)ox...)
Affinity DataIC50: <100nMAssay Description:The capability of compounds described herein to inhibit the enzymatic activity of vascular adhesion protein-1 (VAP-1) was determined by fluorometric ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetMembrane primary amine oxidase(Homo sapiens (Human))
Acucela

US Patent
LigandPNGBDBM619616((E)-2-(((2-(2-oxa-6-azaspiro[3.3]heptan-6-yl)benzo...)
Affinity DataIC50: <100nMAssay Description:The capability of compounds described herein to inhibit the enzymatic activity of vascular adhesion protein-1 (VAP-1) was determined by fluorometric ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetMembrane primary amine oxidase(Homo sapiens (Human))
Acucela

US Patent
LigandPNGBDBM619617((E)-2-(((2-butyl-5-methylbenzo[d]oxazol-6-yl)oxy)m...)
Affinity DataIC50: <100nMAssay Description:The capability of compounds described herein to inhibit the enzymatic activity of vascular adhesion protein-1 (VAP-1) was determined by fluorometric ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetMembrane primary amine oxidase(Homo sapiens (Human))
Acucela

US Patent
LigandPNGBDBM619618((Z)-6-((2-(aminomethyl)-3-fluoroallyl)oxy)-N-((2-m...)
Affinity DataIC50: <100nMAssay Description:The capability of compounds described herein to inhibit the enzymatic activity of vascular adhesion protein-1 (VAP-1) was determined by fluorometric ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetMembrane primary amine oxidase(Homo sapiens (Human))
Acucela

US Patent
LigandPNGBDBM619619((E)-3-((6-((2-(aminomethyl)-3-fluoroallyl)oxy)benz...)
Affinity DataIC50: <100nMAssay Description:The capability of compounds described herein to inhibit the enzymatic activity of vascular adhesion protein-1 (VAP-1) was determined by fluorometric ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetMembrane primary amine oxidase(Homo sapiens (Human))
Acucela

US Patent
LigandPNGBDBM619605((Z)-2-((6-((2-(aminomethyl)-3-fluoroallyl)oxy)benz...)
Affinity DataIC50: <100nMAssay Description:The capability of compounds described herein to inhibit the enzymatic activity of vascular adhesion protein-1 (VAP-1) was determined by fluorometric ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetMembrane primary amine oxidase(Homo sapiens (Human))
Acucela

US Patent
LigandPNGBDBM619621((Z)-2-((6-((2-(aminomethyl)-3-fluoroallyl)oxy)benz...)
Affinity DataIC50: <100nMAssay Description:The capability of compounds described herein to inhibit the enzymatic activity of vascular adhesion protein-1 (VAP-1) was determined by fluorometric ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetMembrane primary amine oxidase(Homo sapiens (Human))
Acucela

US Patent
LigandPNGBDBM619622((Z)-2-(((2-Butyl-1-methyl-1H-benzo[d]imidazol-6-yl...)
Affinity DataIC50: <100nMAssay Description:The capability of compounds described herein to inhibit the enzymatic activity of vascular adhesion protein-1 (VAP-1) was determined by fluorometric ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetMembrane primary amine oxidase(Homo sapiens (Human))
Acucela

US Patent
LigandPNGBDBM619623((Z)-6-((2-(aminomethyl)-3-fluoroallyl)oxy)-N-((2-m...)
Affinity DataIC50: <100nMAssay Description:The capability of compounds described herein to inhibit the enzymatic activity of vascular adhesion protein-1 (VAP-1) was determined by fluorometric ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetMembrane primary amine oxidase(Homo sapiens (Human))
Acucela

US Patent
LigandPNGBDBM619624((Z)-6-((2-(aminomethyl)-3-fluoroallyl)oxy)-N-((2-m...)
Affinity DataIC50: <100nMAssay Description:The capability of compounds described herein to inhibit the enzymatic activity of vascular adhesion protein-1 (VAP-1) was determined by fluorometric ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetMembrane primary amine oxidase(Homo sapiens (Human))
Acucela

US Patent
LigandPNGBDBM619625((Z)-6-((2-(aminomethyl)-3-fluoroallyl)oxy)-N-((6-m...)
Affinity DataIC50: <100nMAssay Description:The capability of compounds described herein to inhibit the enzymatic activity of vascular adhesion protein-1 (VAP-1) was determined by fluorometric ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetMembrane primary amine oxidase(Homo sapiens (Human))
Acucela

US Patent
LigandPNGBDBM619626((Z)-3-((6-((2-(aminomethyl)-3-fluoroallyl)oxy)benz...)
Affinity DataIC50: <100nMAssay Description:The capability of compounds described herein to inhibit the enzymatic activity of vascular adhesion protein-1 (VAP-1) was determined by fluorometric ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetMembrane primary amine oxidase(Homo sapiens (Human))
Acucela

US Patent
LigandPNGBDBM619627((Z)-4-((6-((2-(aminomethyl)-3-fluoroallyl)oxy)benz...)
Affinity DataIC50: <100nMAssay Description:The capability of compounds described herein to inhibit the enzymatic activity of vascular adhesion protein-1 (VAP-1) was determined by fluorometric ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetMembrane primary amine oxidase(Homo sapiens (Human))
Acucela

US Patent
LigandPNGBDBM619628((Z)-6-((2-(aminomethyl)-3-fluoroallyl)oxy)-2-butyl...)
Affinity DataIC50: <100nMAssay Description:The capability of compounds described herein to inhibit the enzymatic activity of vascular adhesion protein-1 (VAP-1) was determined by fluorometric ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
Displayed 1 to 50 (of 357 total ) | Next | Last >>
Jump to: